Augmedix, Inc. provided revenue guidance for the fourth quarter of 2022. Given the strength of its recent bookings and the health of its current backlog, the company expects revenue in the fourth quarter of 2022 to be approximately $8.5 million to $8.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9181 USD | -8.19% | -19.46% | -84.31% |
29/05 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
14/05 | Maxim Downgrades Augmedix to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.31% | 4.5Cr | |
+12.50% | 6.88TCr | |
+7.35% | 1.74TCr | |
+21.91% | 1.36TCr | |
+8.66% | 1.34TCr | |
+12.95% | 979.86Cr | |
-19.05% | 674.36Cr | |
-4.74% | 595.01Cr | |
+2.67% | 523.46Cr | |
-3.21% | 485.04Cr |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022